Home > Insider Trading > Filing (0001144204-19-002146)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1069899	Phibro Animal Health Corp	PAHC	Pharmaceutical Preparations (2834)	131840497

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1601576	M Daniel Bendheim	300 Frank W. Burr Boulevard Suite 21 Teaneck NJ 07666	Exec. Vp, Corporate Strategy	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Acquisiton	2019-01-16	2,500	$11.83	2,500	No	4	M	Direct
Class A Common Stock	Disposition	2019-01-16	2,500	$32.40	0	No	4	S	Direct
Class A Common Stock	Acquisiton	2019-01-17	2,500	$11.83	2,500	No	4	M	Direct
Class A Common Stock	Disposition	2019-01-17	2,500	$32.24	0	No	4	S	Direct
Class A Common Stock	Acquisiton	2019-01-18	2,500	$11.83	2,500	No	4	M	Direct
Class A Common Stock	Disposition	2019-01-18	2,500	$32.04	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Option to purchase Common Stock	Disposition	2019-01-16	2,500	$0.00	2,500	$11.83
Class A Common Stock	Option to purchase Common Stock	Disposition	2019-01-17	2,390	$0.00	2,390	$11.83
Class A Common Stock	Option to purchase Common Stock	Disposition	2019-01-17	110	$0.00	110	$11.83
Class A Common Stock	Option to purchase Common Stock	Disposition	2019-01-18	2,500	$0.00	2,500	$11.83

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,390	2013-03-01	2019-02-28	No	4	M	Direct
0	2013-03-01	2019-02-28	No	4	M	Direct
19,780	2014-03-01	2019-02-28	No	4	M	Direct
17,280	2014-03-01	2019-02-28	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.13 to $32.51, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.09 to $32.42, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.88 to $32.19, inclusive.